{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:28:13Z","timestamp":1761823693904},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1010,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1038\/mtm.2014.46","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T15:03:49Z","timestamp":1412175829000},"page":"14046","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo"],"prefix":"10.1016","volume":"1","author":[{"given":"Andrew W","family":"Hudacek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fetweh H","family":"Al-Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallory","family":"Willet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis","family":"Eisemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Mattis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance L","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias J","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mtm.2014.46_bib1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"Dover","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1038\/mtm.2014.46_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1038\/mtm.2014.46_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.vetmic.2012.11.009","article-title":"Improved detection methods by genetic and immunological techniques for botulinum C\/D and D\/C mosaic neurotoxins","volume":"162","author":"Nakamura","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1038\/mtm.2014.46_bib4","series-title":"Botulism in the United States, 1899\u20131996","year":"1998"},{"issue":"suppl 4","key":"10.1038\/mtm.2014.46_bib5","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mib.2012.05.009","article-title":"Vaccines against botulism","volume":"15","author":"Karalewitz","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1038\/mtm.2014.46_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"issue":"suppl 5","key":"10.1038\/mtm.2014.46_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions","volume":"8","author":"Aoki","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1038\/mtm.2014.46_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tim.2004.08.002","article-title":"Presynaptic receptor arrays for clostridial neurotoxins","volume":"12","author":"Montecucco","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1038\/mtm.2014.46_bib10","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/IAI.01893-06","article-title":"Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route","volume":"75","author":"Ravichandran","year":"2007","journal-title":"Infect Immun"},{"key":"10.1038\/mtm.2014.46_bib11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1038\/mtm.2014.46_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4161\/hv.6.6.11709","article-title":"Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen","volume":"6","author":"Gao","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1038\/mtm.2014.46_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.vaccine.2012.12.054","article-title":"Oral vaccination with an adenovirus-vectored vaccine protects against botulism","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib14","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2012.04.064","article-title":"RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neutrotoxin type A vaccine","volume":"30","author":"Yuki","year":"2012","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2012.11.035","article-title":"Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system","volume":"189","author":"Villaflores","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1038\/mtm.2014.46_bib16","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"key":"10.1038\/mtm.2014.46_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1038\/mtm.2014.46_bib18","doi-asserted-by":"crossref","first-page":"e69692","DOI":"10.1371\/journal.pone.0069692","article-title":"Production and evaluation of a recombinant chimeric vaccine against clostridium botulinum neurotoxin types C and D","volume":"8","author":"Gil","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mtm.2014.46_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.110.175018","article-title":"Evidence that botulinum toxin receptors on epithelial cells and neuronal cells are not identical: implications for development of a non-neurotropic vaccine","volume":"336","author":"Elias","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/mtm.2014.46_bib20","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1016\/j.vaccine.2011.04.045","article-title":"Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge","volume":"29","author":"Mustafa","year":"2011","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib21","doi-asserted-by":"crossref","first-page":"e1003389","DOI":"10.1371\/journal.ppat.1003389","article-title":"Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine","volume":"9","author":"Blaney","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1038\/mtm.2014.46_bib22","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib23","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1016\/j.vaccine.2012.07.073","article-title":"Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein","volume":"30","author":"Papaneri","year":"2012","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib24","doi-asserted-by":"crossref","first-page":"13455","DOI":"10.1128\/JVI.78.24.13455-13459.2004","article-title":"Immunogenicity study of glycoprotein-deficient rabies virus expressing simian\/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque","volume":"78","author":"McKenna","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"key":"10.1038\/mtm.2014.46_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2006.05.010","article-title":"Rabies virus glycoprotein as a carrier for anthrax protective antigen","volume":"353","author":"Smith","year":"2006","journal-title":"Virology"},{"key":"10.1038\/mtm.2014.46_bib27","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","article-title":"Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles","volume":"93","author":"Schnell","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtm.2014.46_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib29","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.78.6.3196-3199.2004","article-title":"Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein","volume":"78","author":"Roberts","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib30","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1128\/JVI.76.15.7642-7650.2002","article-title":"Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression","volume":"76","author":"Wertz","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-1702(02)00047-3","article-title":"Recombinant Sendai viruses expressing different levels of a foreign reporter gene","volume":"86","author":"Tokusumi","year":"2002","journal-title":"Virus Res"},{"key":"10.1038\/mtm.2014.46_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1006\/viro.2001.1058","article-title":"Mechanisms of loss of foreign gene expression in recombinant vesicular stomatitis viruses","volume":"287","author":"Qui\u00f1ones-Kochs","year":"2001","journal-title":"Virology"},{"key":"10.1038\/mtm.2014.46_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1038\/mtm.2014.46_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jviromet.2006.02.006","article-title":"An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development","volume":"135","author":"Witko","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1038\/mtm.2014.46_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2008.05.009","article-title":"An improved method for development of toxoid vaccines and antitoxins","volume":"337","author":"Jones","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1038\/mtm.2014.46_bib36","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1128\/IAI.00166-11","article-title":"Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells","volume":"79","author":"White","year":"2011","journal-title":"Infect Immun"},{"key":"10.1038\/mtm.2014.46_bib37","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.vaccine.2013.03.046","article-title":"Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors","volume":"31","author":"Yu","year":"2013","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib38","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib39","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1016\/j.vaccine.2007.10.016","article-title":"Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A","volume":"25","author":"Yu","year":"2007","journal-title":"Vaccine"},{"key":"10.1038\/mtm.2014.46_bib40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1038\/mtm.2014.46_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anaerobe.2014.06.003","article-title":"Production of recombinant botulism antigens: A review of expression systems","volume":"28C","author":"Moreira","year":"2014","journal-title":"Anaerobe"},{"key":"10.1038\/mtm.2014.46_bib42","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/mtm.2014.46_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, present, and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1038\/mtm.2014.46_bib44","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1084\/jem.20100995","article-title":"A requirement for Fc\u03b3R in antibody-mediated bacterial toxin neutralization","volume":"207","author":"Abboud","year":"2010","journal-title":"J Exp Med"},{"key":"10.1038\/mtm.2014.46_bib45","doi-asserted-by":"crossref","first-page":"e01007","DOI":"10.1128\/mBio.01007-14","article-title":"Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice","volume":"5","author":"Varshney","year":"2014","journal-title":"MBio"},{"key":"10.1038\/mtm.2014.46_bib46","doi-asserted-by":"crossref","first-page":"e01414","DOI":"10.1128\/mBio.01477-14","article-title":"The road to toxin-targeted therapeutic antibodies","volume":"5","author":"Kozel","year":"2014","journal-title":"MBio"},{"key":"10.1038\/mtm.2014.46_bib47","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/JVI.75.14.6418-6427.2001","article-title":"The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity","volume":"75","author":"von Messling","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mtm.2014.46_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JVI.01309-10","article-title":"Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV","volume":"85","author":"Wirblich","year":"2011","journal-title":"J Virol"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050116301140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050116301140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T08:04:26Z","timestamp":1598342666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050116301140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":48,"alternative-id":["S2329050116301140"],"URL":"https:\/\/doi.org\/10.1038\/mtm.2014.46","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"article-number":"14046"}}